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1. Introduction 
Myocardial perfusion imaging (MPI) was developed in the 1970s and has been used 
increasingly in clinical cardiology since the 1980s (Underwood et al., 2004). Technical 
developments that have fuelled this recent increases are single-photon emission computed 
tomography (SPECT) imaging, pharmacological stress and ECG-gated SPECT imaging. MPI 
comprises the only widely available method of assessing myocardial perfusion directly and 
many previously published reports support its evidence in the diagnosis of myocardial 
ischemia and necrosis. Moreover, the prognostic value of this method for patients’ risk 
stratification has already been extensively reported, with an incremental prognostic value 
after clinical assessment, exercise electrocardiography and even above coronary 
angiography. Thus, MPI is an established imaging technique that is already an integral part of 
the management of coronary artery disease (CAD) (diagnosis, prognostication, selection for 
revascularization and assessment of acute coronary syndromes) and is included in a number of 
professional guidelines. (1, 2) 
In the past two decades, a great body of literature has established the use of nuclear imaging 
for risk stratification in patients with known or suspected CAD. Risk stratification is of 
crucial importance for the practice of contemporary medicine. Extending the paradigm of 
noninvasive cardiac testing beyond the detection of disease is especially important, may risk 
assessment permits patients who are identified as being at a high risk for subsequent cardiac 
events should receive aggressive management, possibly including cardiac catheterization for 
potential revascularization procedures that may improve their outcome. Conversely, the 
management focus in patients with low future event rate should be shifted toward risk 
factor modification and aggressive medical therapy, reserving invasive procedures for 
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patients who fail medical management. CAD is disease with a wide spectrum of severity 
and extent with outcome, such as nonfatal myocardial infarction (MI) or cardiac death being 
related to the severity of disease. Clinical trials have shown that patients with severe CAD 
as left main coronary artery disease, especially those with left ventricular dysfunction, can 
benefit from coronary artery bypass graft surgery (CABG) with significant reduction in their 
mortality rate (1, 2, 3). Whereas patients with single-vessel or with two-vessel disease 
(without proximal left anterior descending artery involvement) would have improved 
symptoms of angina following CABG  and percutaneous transluminal coronary angioplasty 
with or without stent implantation, without any effect on their mortality rate.  
Risk assessment based on clinical finding and resting ECG only is limited. Exercise testing 
can also help, especially when examining the patient's functional capacity. Exercise-induced 
ECG changes and risk indices also have substantial prognostic value. Unfortunately most 
patients (55%) with suspected CAD would fall in an intermediate-risk group, necessitating 
additional risk stratification.  
Coronary angiography, considered the “gold standard” for the diagnosis of CAD, often does 
not provide information about the physiologic significance of atherosclerotic lesions, 
especially in borderline lesions. More importantly, it does not provide a clear marker of risk 
of adverse events, especially in patients with moderate disease severity. Andreas Gruentzig 
said; “When coronary angiography founded coronary artery disease, I would like to have diagnostic 
procedure who will give me functional significance that lesion.”(2, 3, 4, 5)   
2. Risk based on nuclear imaging results 
Determination culprit lesion  
The current definition of culprit lesion; that is zone of ischemia under the coronary stenoses (what 
degree?) That is not quite good definition. Some autors offer degree of coronary stenoses ≤ 70 
%, some ≤ 75%, even < 80-85% ) but is not quite wright, because that is not definy two 
pathophysiologic aspects of ischemia; severity and extent. Ladenhaim et al. have also shown 
that the magnitude of ischemia (severity and extent) correlates well with cardiac events. 
Some other autors shown correlation between event rate (death, nofatal IM and 
revascularization) and extent of ischemia demonstrated by the number of ischemic segments 
on SPECT scan. Iskander and Iskadrian have also shown that defects reversibility is an 
important predictor of type of cardiac events, whereas reversible perfusion defects are 
associated with nonfatal MI. This is very important finding, since a reversible defect on the 
myocardial perfusion imaging (MPI) by single photon-emission computed tomography 
(SPECT) is the only available diagnostic tool that can independently predict the risk of 
nonfatal MI. Therefore, stress perfusion studies should be reported documenting defect 
severity (mild, moderate, severe), size (small, moderate, large) and reversibility to provide 
essential risk stratification (2, 4, 5, 6).  
The value of MPI comes from the ability to identify and quantify the degree of jeopardized 
myocardium during stress tests. The size and severity of the perfusion abnormality provide 
powerful prognostic information and has been shown to directly relate to outcome. SPECT 
perfusion imaging and determination of culprit lesion is more predicitble of cardiac events 
than coronary angiography. As SPECT imaging may identify those patients at high risk for 
subsequent cardiac events, perfusion imaging may be used to help guide further testing and 
revascularization procedures, and this obviously has important cost-effectiveness 
ramifications. 
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The primary objective of those study was to determinate and localizes culprit lesion by 
knew introduce parameters SRS (summary reversible score) and ISRS (index of summary 
reversible score), under the angiographically detected coronary narrowing ≥75% for the least 
one coronary artery (2, 14).  
A welt of literature supports the use of MPI for risk stratification in patients with known or 
suspected CAD. The ability of SPECT imaging to localize and define the culprit lesion 
(extent/severity) of disease predicts subsequent cardiac events such as MI or cardiac death. 
Furthermore, specific applications of these nuclear cardiology techniques, such as post 
infarction or in patients with unstable angina, have also successfully assessed risk of 
cardiovascular events. The prognostic applications of perfusion imaging are germane to all 
health care providers, as these methods may be used to guide subsequent tests and 
treatments. MPI has significantly impact on patient management decisions and the cost-
effective utilization of health care. 
The rapid rate of technical advances and improved operator expertise has enabled this 
technique to gain more widespread application. Despite the large number of PTCA 
performed yearly, preprocedure documentation of myocardial ischemia is uncommon, 
occurring in only 29% of patients. Despite the obvious value of nuclear cardiology to detect, 
localize, and define the extent of ischemia, this procedure appears underutilized before 
performance of percutaneous intervention. It is unclear whether this reflects an under 
utilization of noninvasive methods to objectively justify the performance of PTCA or 
whether the addition of such techniques is considered superfluous. 
Myocardial perfusion imaging provides information on the extent and location of 
myocardial ischemia. The assessment of jeopardized myocardium may be performed and 
provides a measure of the relative value of PTCA in terms of the amount of jeopardized 
myocardium. The location of the stenosis may dictate the area at risk: extent and severity of 
perfusion defects were significantly smaller in patients with proximal compared with distal 
coronary artery occlusions (2, 14).  
Before revascularization is performed, myocardial perfusion imaging may assist in 
management decisions by demonstrating the presence of myocardial ischemia, viability and 
delineating the severity and extent of coronary artery disease. The significance of equivocal 
lesions may be determined and culprit vessel may be successfully defined by SPECT 
imaging before angioplasty.  
The aim of this study was to determinate and localizes culprit lesion by myocardial 
perfusion imaging (MPI), under the angiographically detected coronary narrowing ≥75% for 
the least one coronary artery. One hundred thirty-two (132) patients with known coronary 
artery disease (CAD) were studied. In all of them angiographically detected significant 
coronary narrowing (≥75% luminal stenosis for the least one coronary artery). Al patients 
submitted MPI 99mTc-MIBI, with pharmacologic adenosine stress protocol with concomitant 
low level bicycle exercise 50W (AdenoEX). We were measured relative uptake 99mTc-MIBI 
for each myocardial segment using short-axis myocardial tomogram study. A 5-point 
scoring system was used to assess difference between uptake degree in stress and rest 
studies for the same segments, and we were created two index; Sum reversibility score 
(SRS), Index of sum reversibility score (ISRS). Results: A total of 396 vascular territories 
(2244 segments) were analyzed before elective percutaneous coronary intervention (ePCI). 
Overall sensivity, specificity, and accuracy using SS were 90.2%, 87.5%, 89.4%, with positive 
predictive value 94, 1%. Overall sensitivity, specificity, and accuracy using ISRS were 94.4%, 
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90.6%, 93, 2%, with positive predictive value 95, 7%. Conclusion: MPI with two created 
index SRS and ISRS significantly improves sensitivity, specificity, and accuracy for 
determination culprit lesion in patients undergoing PCI. Conclusion: AdenoEX MPI 
significantly improves sensitivity, specificity, and accuracy for determination and 
localization culprit lesion in patients undergoing ePCI. 
3. Coronary artery disease – exercise and pharmacologic stress test 
Coronary artery disease (CAD) is still single greatest cause of death of men and women. In 
the USA more than 9 million patients are referred yearly for diagnostic cardiac stress test 
with radionuclide imaging. Although an increasing number of patients undergo 
pharmacologic stress because they are unable to perform adequate physical stress, such as 
maximal workload, duration, hemodynamic response, exercise-induced symptoms, and 
electrocardiography (ECG) changes, provide invaluable additional information for assessing 
a patients condition not available with pharmacologic stress. Pharmacologic stress testing 
accounts for approximately 48% of stress myocardial perfusion studies done to detect CAD 
in the US. Exercise stress test is preferred for patients who can exercise and achieve 
adequate exercise endpoints. Pharmacologic stress testing is reserved for patients who have 
exercise limitations. It is estimated that at least 25% of patients and 50% of hospitalized 
patients cannot perform maximal exercise. Pharmacologic stress can be done with 
vasodilator agents (adenosine, dipyridamole, adenosine triphosphate, or selective adenosine 
A2a receptor agonist) or with inotropic and chronotropic agents (dobutamine or 
arbutamine). Patients with left bundle branch block (LBBB) or electronically paced rhythms 
may have anteroseptal perfusion defects with exercise or dobutamine perfusion imaging 
unrelated to stenosis of the left anterior descending artery and hence vasodilator stress 
testing is recommended in these patients (6, 7, 8, 9).  
Adenosine and dipyridamole stress have been used in combination with exercise especially 
in patients with limited exercise capacity. The reported benefits of the combination protocols 
include improvement in ischemia detection and image quality, and reduction in side effects. 
The addition of exercise to vasodilator stress might partly overcome the roll-off 
phenomenon observed with vasodilators alone resulting in more radiotracer extraction and 
better estimation of CAD. 
Simultaneous exercise in conjunction with adenosine stress was safe and significantly 
reduced adenosine side effects by 30%-40% and enhanced image quality. These benefits 
were similar with sub maximal or maximal exercise (6-9, 10)  
Similar to adenosine, patients who underwent dipyridamole-exercise had fewer noncardiac 
side effects, more ischemic ECG changes, higher HR and systolic BP, and better image 
qualities with increased heart to liver and heart to gut count ratios.   
One of the most powerful uses of MPI is the evaluation of the risk for future events in 
patients with suspected or known CAD. Over the years, MPI has evolved as an essential tool 
in the evaluation and assessment of patient prior to coronary revascularization. It has a dual 
role. Prior to coronary angiography, MPI is extremely useful in documenting ischemia and 
determining the functional impact of single or multiple lesions identified subsequently. MPI 
remains the test of choice for identifying the lesion responsible for the ischemic symptoms, 
or so called culprit lesion. That is extremely useful for further management decisions with 
respect to percutaneous interventions. In compare, the absence of reversible ischemia in 
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patients with known CAD is an excellent prognostic marker and predicts a low annual 
event rate. The current definition of culprit lesion that is zone of ischemia under the 
coronary stenoses is not quite right, because that is not defined two pathophysiologic 
aspects of ischemia; severity and extent. The primary objective of those study was to 
determinate and localizes culprit lesion by knew introduce parameters SRS (summary 
reversible score) and ISRS (index of summary reversible score), under the angiographically 
detected coronary narrowing ≥75% for the least one coronary artery (2, 14). 
4. Methods 
One hundred thirty-two (132) patients with known CAD were studied. In all of them 
angiographically detected significant coronary narrowing (≥75% luminal stenosis for the 
least one coronary artery). All patients were submitted to 2 iv injections of 99mTc-MIBI, one 
in a peak pharmacologic stress test with concomitant low level exercise stress test (50W) 
AdenoEx protocol; we administered adenosine (in the dose of 140 μg/kg/min) in 
combination with supine bicycle exercise low level 50W. We started infusion at the end of 
the 1st minute bicycle exercise, and finished in the 5th minute. Bicycle exercise was 
continuing one minute more until 6th minute. Radiopharmaceutical 99mTc-MIBI was 
administrated during the infusion at the end of 2nd minute. Imaging started 15 minutes 
after iv. 99mTc-MIBI 740 MBq and the other 370 MBq at rest 3 hour after in the rest study.  
Images of the heart were taken; 15 min after injections for the stress studies, and 30 minutes 
after injections for the rest study, using an Orbiter Siemens gamma camera, which was fitted 
with a low energy, all purpose collimator, and connected with a dedicated computer system. 
Briefly, 32 projections were obtained over a semicircular 1800 arch wich extended from the 
anterior 00 to the left posterior position 1800. In each patient, we were using Stirner 
quantification program (Euro menu) modificated and standardized myocardial 
segmentation and nomenclature for topographic imaging of the heart analyzed SPECT. 
Quantification regional 99mTc-MIBI uptake was performed using short-axis myocardial 
tomography that was divided on 16 segments + apex for each study (2, 11).  
The left anterior descedenting artery (LAD) vascular territory including; basal anterior, basal 
anteroseptal, mid anterior, mid anteroseptal, apical anterior, apical septal, and apex; Left 
circumflex artery (LCx); basal inferolateral, basal anterolateral, mid inferolateral, mid 
anterolateral, apical lateral; Right coronary artery (RCA); basal inferoseptal, basal inferior, 
mid inferoseptal, mid inferior, apical inferior.  
We were measured relative uptake, in area individual coronary artery vascular territory, 
from each segment and compare with the segment with the best uptake, and we founded in 
the AdenoEx study; Normal relative uptake (> 85%); Probably normal (75%-85%); Equivocal 
(65%-75%); Probably abnormal (50%-65%); Abnormal (< 50%). Rest study; Normal relative 
uptake (> 90%); probably normal (80%-90%); equivocal (70%-80%); probably abnormal 
(55%-75%); abnormal (< 55%). Different between relative uptake each segment we were 
scoring with a 5-point scoring system to ass’s difference between uptake degree in stress 
and rest studies for the same segments (1= normal, 2= mild ischemia, 3= moderate ischemia, 
4= reversibility, 5= severe reversibility).  
We were introduced two knew index score to determinate culprit lesion. Summary 
reversible score (SRS) ≥ 3 in the territory of stenoses coronary artery was determinate 
culprit lesion. At least two segments with score 5 (index of summary reversible score- 
ISRS) in the territory of stenoses coronary artery was determinate culprit lesion. 
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Results: A total of 396 vascular territories (2244 segments) were analyzed before elective 
percutaneous coronary intervention (ePCI). Overall sensitivity, specificity, and accuracy 
using SS were 90.2%, 87.5%, 89.4%, with positive predictive value 94,1%. Overall sensitivity, 
specificity, and accuracy using ISRS were 94.4%, 90.6%, 93, 2%, with positive predictive 
value 95, 7%. Conclusion: MPI with two created index SRS and ISRS significantly improves 
sensitivity, specificity, and accuracy for determination culprit lesion in patients undergoing 
PCI. 
5. State of the art and future directions 
Since the introduction of myocardial perfusion imaging (MPI) into clinical medicine in late 
1970s, this technique has undergone considerable expansion and evolution. Initially, 
myocardial perfusion imaging was introduced as a noninvasive diagnostic tool in 
determining the presence or absence of coronary artery disease (CAD).  
The ability to distinguish patients at low risk from those at high risk for future cardiac 
events has become an essential adjunct for clinicians in the management of patients of 
CAD.  The power of myocardial perfusion imaging (MPI) for predicting future coronary 
events has been demonstrated in a large number of high-quality studies and in many 
thousands of patients. It is perhaps the area of nuclear cardiology where the evidence is 
most strong. The most important variables that predict the likelihood of future events are 
the extent and severity of inducible ischemia. In general, markers of left ventricular 
dysfunction tend to predict cardiac mortality and inducible ischemia predicts acute 
coronary syndromes. MPI has incremental prognostic value even after clinical assessment, 
exercise electrocardiography and coronary angiography. In other words, patients who 
appear to be high risk after coronary angiography can be separated into higher and lower 
risk groups by MPS. In addition, several studies have indicated that a negative SPECT 
study confers an excellent prognosis with an annual cardiac event rate of <1% for the 
general population. In the setting of a normal myocardial perfusion study in a low-risk 
patient, it takes 9 years for the risk of a cardiac event to reach 1%, suggesting that, in the 
absence of new symptoms, a repeat perfusion study may not be needed for 3 to 5 years 
(13, 14, 15). However, this "warranty period" does not appear to be absolute and is 
affected by clinical and technical factors, including the presence of diabetes or CAD, 
increasing age and male gender, and the need to perform a pharmacologic stress test 
rather than an exercise perfusion imaging test, which can increase the annual cardiac 
event rate in patients with a normal perfusion scan to as high as 1.8%. In these high-risk 
patients with normal myocardial perfusion studies, it may be prudent to perform repeat 
perfusion imaging on a more frequent basis.  
Because of its prognostic power, MPI can be used as the gatekeeper to coronary 
angiography. Bateman and colleagues showed that referral to coronary angiography after 
normal, mild to moderately abnormal and severely abnormal perfusion scans was 3.5%, 9% 
and 60% respectively. Importantly, a policy of selective referral to coronary angiography 
based upon high-risk findings is defensible, as patients with mild to moderate abnormalities 
when managed medically have outcomes comparable to those undergoing invasive 
evaluation and subsequent revascularization. Besides, several reports underlie that such a 
policy can be also cost-effective even if it is more expensive than an alternative test such as 
the exercise ECG. Furthermore, MPS can provide useful information about cardiac risk in 
patients requiring non-cardiac surgery although these patients are generally at low risk and 
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the predictive value of a normal perfusion study is greater than that of an abnormal study, 
while the clinical value of MPS to assess patients with acute coronary syndrome has been 
well established. 
MPS is of proven value to assess patients post revascularization. Information gained from 
post-intervention myocardial SPECT is important to differentiate patients with angina 
from those with echo-cardiac chest pain syndromes, to assess peri-intervention 
myocardial damage/acute vessel closure, to predict-detect restenosis after PCI and graft 
occlusion/stenosis after CABG surgery, to detect CAD progression in non-revascularized 
vessels, to evaluate the effects of intervention if required for occupational reasons and to 
predict patients’ long-term prognosis (16, 17).  
The assessment of patients’ prognosis is central to the clinical management of patients with 
CAD. Patients with CAD can be characterized along a continuum of risk for cardiac events. 
When the risk of cardiac events low, cardiologists generally employ conservative medical 
management. Conversely, when the risk of cardiac events is high, aggressive patient 
management, such as the performance of coronary bypass surgery or coronary angioplasty, 
tends to be favored. Between these extremes of risk, are a large number of patients who have 
an intermediate risk of cardiac events, which can be arbitrary and roughly defined as a 
likelihood of from 2% to 5% of major cardiac events over the ensuing year. Decision making 
to such patients is challenging, since the indication for conservative versus aggressive 
treatment is most uncertain in this group. Thus, the clinical often desires additional 
prognostic information about such patient to better define the likelihood of cardiac events. It 
is this group of patients in whom radionuclide stress testing finds its greatest prognostic 
benefit. The prognostic utility of radionuclide stress tests derives from their ability to 
quantify the magnitude of jeopardized myocardium during exercise or during 
pharmacologic stress testing with dipyridamole or adenosine. Specifically, MPI measures 
two indices of ischemia: ischemic extent and ischemic severity. Ischemic extent indices 
reflect the area of myocardial mass that became during stress. Ischemic severity indices 
correlate roughly with the number of stenosed coronary arteries. The number of reversible 
myocardial perfusions defects seen by MPI SPECT, constitutes a typical variable of ischemic 
extent. By contrast, ischemic severities indices reflect the magnitude of inducible ischemia 
within a given myocardial region. For instance, the severity of a perfusion defects reflects 
the severity of subtending coronary stenoses. Variables of ischemia extent and severity that 
can be assessed with stress myocardial perfusion SPECT are shown in the Table 1. 
Included in this list are two variables that may be assessed by obtaining an early anterior 
planar scintigram before SPECT imaging: a) the post-stress lung uptake of isotope, and b) 
the transient post-stress ischemic dilatation of the left ventricle. 
Because of its clinical importance, information about the extent and severity of jeopardized 
myocardium should be incorporated into the routine reporting of radionuclide stress test 
results. Conventional practice is to divide the short axis of the left ventricle into the three 
regions: apical, mid-ventricular and basal. The apex is assessed from the vertical long axis 
slices. Our approach is to assess the reduction in regional uptake of isotope in each of the 17 
myocardial segments. On a five-point scale, as follows: 1 = none, 2 = mild, 3 = moderate, 4 = 
severe and 5 = complete reduction in regional uptake. Comparison of the stress and rest scores 
provides the physician with a quantitative estimation of the degree of reversibility of each 
myocardial defect. From the location of defects, it can be estimated which coronary vessels are 
the most likely culprit lesions for the induction of myocardial ischemia (2, 10, 16, 17, 18).  
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Predictor Ischemia Extent Ischemia Severity 
- Number and/or location 
of reversible defections 
- Magnitude of defects 
- Delayed redistribution 
- Lung uptake of isotopeª 
- Transient LV dilatationª  
- Magnitude of WMA¹ 
- Number/location of 
WMA¹ 
- Change in LVEF stress¹ 
++++ 
 
0 
+ 
+++ 
++++ 
0 
++++ 
+++ 
 
0 
 
++++ 
++++ 
+ 
++++ 
++++ 
0 
++ 
 
ªBest assessed by obtaining a 5-minute and 4-hour anterior planar scintigram before the initiation of 
SPECT imaging. 
¹Obtained from concomitant rest-exercise first-pass radionuclide ventriculography when employing 
99mTc-agents.  
LV left ventricle; WMA wall-motion abnormality; EF ejection fraction 
Table 1. Predictors of stress-induced ischemia extent and severity using SPECT and 
adjunctive scintigrams. 
The relationship between the magnitude of inducible myocardial ischemia and the 
likelihood of cardiac events is not linear. Previous investigation has shown that the 
magnitude of ischemia has an exponential relationship to the occurrence of subsequent 
cardiac events. Patients who demonstrate only mild ischemia at a peak stress have only a 
small, relatively flat increase in the likelihood of cardiac events as compared to patients who 
manifest no scintigraphic evidence of inducible ischemia. But, once ischemia progressed to a 
moderate magnitude, the likelihood of cardiac events begins to increase sharply. Ladenheim 
and colleagues performed a 1-year follow-up of 1.689 patients without prior myocardial 
infarction (MI) who underwent exercises planar MPI for diagnostic or prognostic purposes. 
The frequency of hard cardiac events (MI/cardiac death) and late (> 60 days) bypass 
surgery after testing were recorded as cardiac events. Ischemic extent and ischemic severity 
were exponentially related to the cardiac event rate (2, 17, 18).  
Based on the published prognostic literature, four points may be derived that can serve as 
general rules of thumb for the utilization of scintigraphic testing in clinical practice: 
6. Use of radionuclide stress testing in patient-management decision 
- Risk assessment in patients with a high likelihood of CAD 
- Selection of therapy in patients with angiographically documented CAD; 
- Selection between medical therapy versus revascularization. 
- Identification of culprit lesions prior to coronary intervention. 
- Evaluation of borderline coronary artery stenosis. 
- Risk stratification of post-MI patients 
- Predischarge exercise testing. 
- Predischarge pharmacological stress testing. 
- Evaluation of patients following thrombolysis. 
- Predischarge evaluation of patients with unstable angina 
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- Risk stratification of the elderly 
- Risk stratification of patients with congestive heart failure and/or left ventricular 
dysfunction 
- Evaluation of patients following treatment modalities for CAD 
- Percutaneous coronary intervention 
- Coronary artery by-pass surgery 
- Medical therapy 
- Risk stratification of patients prior to elective noncardiac surgery 
Substitution of pharmacological stress testing for risk stratification. In general, the 
performance of myocardial perfusion scintigraphy with exercise as opposed to 
pharmacological stress is preferable for prognosis purposes. Important prognostic variables 
associated with exercise ECG testing include exercise capacity, exercise-inducible chest pain 
or hypotension, and the ECG response to exercise, particularly the heart rate threshold and 
post-exercise duration of stress-induced ST-segment depression. These variables cannot be 
assessed when pharmacologic instead of exercise testing is employed. 
However, the performance of myocardial perfusion imaging in conjunction with 
pharmacologic stress testing, either with dipyridamole or with adenosine, has essentially the 
same sensitivity and specificity for detecting CAD as does exercise myocardial perfusion 
scintigraphy. Moreover, studies done with both modalities indicate that magnitude of 
ischemic defects induces by exercise is not underestimated by those induces by pharmacologic 
stress. A normal scintigraphic study in association with pharmacological stress is associated 
with a same low risk of cardiac events as is a normal exercise myocardial perfusion study. 
Dipyridamole or adenosine SPECT is commonly employed as the pharmacological stress 
agent, given its ease to use. Myocardial perfusion imaging (MPI) can also be performed in 
conjunction with dobutamine or arbutamine stress, but is generally reserved for patients with 
asthma or chronic lung disease. Despite the theoretical advantages of exercise in assessment 
prognosis, excellent risk stratification has been reported with adenosine SPECT imaging, with 
results similar to those observed with exercise. 
Based on the strongly documented prognostic efficacy, MPI has emerged as a key guide for 
major medical decisions involving patients with suspected or known CAD 
Myocardial perfusion imaging provides incremental prognostic value, particularly in 
patients and an intermediate or high pretest likelihood of CAD or patients with stable CAD 
and mild symptoms. Patients who exhibit normal myocardial perfusion and function on 
gated SPECT have an excellent prognosis and should be referred for non cardiac evaluation 
for determining etiology of the presenting symptoms. Conversely, patients with high-risk 
scans may benefit from an early invasive strategy with a view toward revascularization 
depending on coronary anatomical finding. A substantial number of patients undergoing 
SPECT perfusion imaging will have mild ischemia without a multivessel disease scan 
pattern. If patients with mild ischemia have good exercise tolerance, they should be 
considered as candidates for intense medical therapy with follow-up exercise SPECT 
imaging possibly at 1 year. Unpublished data from the Clinical Outcomes Utilizing 
Revascularization and Aggressive Drug Evaluations (COURAGE) trial seem to indicate that 
many ischemic defects may markedly improve with aggressive lowering of abnormal lipids 
an the other pharmacological interventions. Hachamovitch and colleagues reported patients 
with the mildly abnormal scan had a 0.8% annual cardiac death rate compared with 0.9% for 
those who underwent revascularization. The death rate in medically treated patients who 
had moderately abnormal scans was 2.3% versus 1.1% for such patients undergoing 
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revascularization. Finally, patients with a severely abnormal scan treated medically had an 
annual cardiac death rate of 4.6% versus 1.3% for such patients who were revascularized. In 
the second study, these investigators showed that medically treated patients who had 
greater than 20% of the total myocardium rendered ischemic had higher annual cardiac 
death rate (6.7%) compared with 2.0% for patients with this degree of extensive ischemia 
who underwent revascularization. For patients with 10% or less of the total myocardium 
rendered ischemic, there was no difference in outcome between medical therapy and 
revascularization (2, 12, 13, 17, 18).  
Exercise myocardial perfusion imaging is a valuable adjunct for separating high to low risk 
patients who present symptoms consistent with stable CAD, or in patients who have known 
disease and in whom further prognostication is warranted. Multiple high-risk nuclear 
imaging variables can be identified, and the greater the extent of exercise/induced ischemia, 
the greater the risk of cardiac events. Adjunctive variables, such as transient ischemic cavity 
dilatation and functional assessment with evaluation of regional wall thickening or wall 
motion and left ventricular ejection fraction greatly assist in the risk stratification process.  
Nuclear cardiology is uniquely placed to address all the major determinants of prognosis in 
CAD can be assessed by measurements of stress-induced perfusion or function. These 
measurements include the amount of infarcted myocardium, the amount of jeopardized 
myocardium (supplied by vessels with hemodynamically significant stenosis), and the degree 
of jeopardy (tightness of the individual coronary stenosis). Recent evidence in large patient 
cohorts has revealed that factor estimating the extent of left ventricular dysfunction (left 
ventricular ejection fraction, extent of infarcted myocardium, transient ischemic dilatation of 
the left ventricle and increasing lung uptake) are excellent predictors of cardiac mortality. 
However, measurements of inducible ischemia are the best predictors of the development of 
acute coronary syndromes. Several reports have shown that nuclear testing yields incremental 
prognostic value over clinical information with respect to cardiac death, or the combination of 
cardiac death and nonfatal myocardial infarction as isolated endpoints. Now it is possible to 
tailor therapeutic decision making for an individual patient based upon combination of clinical 
factors and nuclear scan results. Patients with severe perfusion abnormalities on their stress 
image may have a five- to ten-fold higher likelihood of cardiac death versus patient with a 
normal myocardial perfusion SPECT. If the defects perfusion determined as a culprit lesion, 
invasive therapy (PCI) is an optimized outcome for that patient (2). 
7. Clinical evaluation of MPS 
The power of myocardial perfusion imaging (MPI) for predicting future coronary events has 
been demonstrated in a large number of high-quality studies and in many thousands of pa-
tients. It is perhaps the area of nuclear cardiology where the evidence is most strong. The 
most important variables that predict the likelihood of future events are the extent and 
severity of inducible ischemia. In general, markers of left ventricular dysfunction tend to 
predict cardiac mortality and inducible ischemia predicts acute coronary syndromes. MPS 
has incremental prognostic value even after clinical assessment, exercise 
electrocardiography and coronary angiography. In other words, patients who appear to be 
high risk after coronary angiography can be separated into higher and lower risk groups by 
MPS. In addition, several studies have indicated that a negative SPECT study confers an 
excellent prognosis with an annual cardiac event rate of <1% for the general population. In 
the setting of a normal myocardial perfusion study in a low-risk patient, it takes 9 years for 
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the risk of a cardiac event to reach 1%, suggesting that, in the absence of new symptoms, a 
repeat perfusion study may not be needed for 3 to 5 years. However, this "warranty period" 
does not appear to be absolute and is affected by clinical and technical factors, including the 
presence of diabetes or CAD, increasing age and male gender, and the need to perform a 
pharmacologic stress test rather than an exercise perfusion imaging test, which can increase 
the annual cardiac event rate in patients with a normal perfusion scan to as high as 1.8%. In 
these high-risk patients with normal myocardial perfusion studies, it may be prudent to 
perform repeat perfusion imaging on a more frequent basis.  
Because of its prognostic power, MPS can be used as the gatekeeper to coronary angiography. 
Bateman and colleagues showed that referral to coronary angiography after normal, mild to 
moderately abnormal and severely abnormal perfusion scans was 3.5%, 9% and 60% re-
spectively. Importantly, a policy of selective referral to coronary angiography based upon 
high-risk findings is defensible, as patients with mild to moderate abnormalities when 
managed medically have outcomes comparable to those undergoing invasive evaluation and 
subsequent revascularization. Besides, several reports underlie that such a policy can be also 
cost-effective even if it is more expensive than an alternative test such as the exercise ECG. 
Furthermore, MPS can provide useful information about cardiac risk in patients requiring non-
cardiac surgery although these patients are generally at low risk and the predictive value of a 
normal perfusion study is greater than that of an abnormal study, while the clinical value of 
MPS to assess patients with acute coronary syndrome has been well established. 
MPS is of proven value to assess patients post revascularization. Information gained from 
post-intervention myocardial SPECT is important to differentiate patients with angina from 
those with echo-cardiac chest pain syndromes, to assess peri-intervention myocardial 
damage/acute vessel closure, to predict-detect restenosis after PCI and graft 
occlusion/stenosis after CABG surgery, to detect CAD progression in non-revascularized 
vessels, to evaluate the effects of intervention if required for occupational reasons and to 
predict patients’ long-term prognosis ( 2, 14, 16, 17, 18).  
 
 
Fig. 1. Culprit lesion on the lateral and inferior segments on the short axis after SPECT MPI 
with AdenoEx protocol. In the rest study (right side) we showed normal finding of 
perfusion in the same area. We indicated invasive strategy. 
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Fig. 2. Occlusion ACx, and subtotal stenosis RCA. In the same acts we perfiormed PCI with 
stent implantation  
 
 
Fig. 3. MPI nearly after PCI (two weeks) showed normal findinig  
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Fig. 4. Rest study showed normal MPI finding; stress two lines short axis below; culprit 
lesion in the anterospetal segments 
 
 
 
Fig. 5. Coronarography finding; subtotal stenosis LAD  
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Fig. 6. In the same acts we performed PCI with stent implantation  
 
 
 
Fig. 7. Two months after we performed MPI for assessment elective PCI theraphy. We fnded 
normal perfusion in the rest (up) and AdenoEx study (below two lines short axis)  
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Fig. 8. Culprit lesion in the inferolateral segments in the AdenoEx (up line slices) MPI study 
 
 
 
 
 
 
Fig. 9.  
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Fig. 10.  
 
 
Fig. 11. Nearly after elective PCI intervention we performed MPI with normal finding of 
perfusion 
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8. Conclusion 
Myocardial perfusion imaging by SPECT, with pharmacologic stress test AdenoEX 
significantly improves sensitivity, specificity, and accuracy for determination and 
localization culprit lesion in patients undergoing elective percutaneous coronary 
intervention.  
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metabolism. Assessing cardiac viability is now fairly routine with these enhancements to cardiac imaging. This
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